Table 2 Odds ratio of developing HSP associated with drugs
From: Henoch-Schönlein purpura and drug and vaccine use in childhood: a case-control study
Drugs | Cases (288) | Controlsa (617) | Crude OR (95 % CI) | Adjusted ORb (95 % CI) |
|---|---|---|---|---|
Antibiotics | 65 | 156 | 0.7 (0.5–1.0) | 1.0 (0.7–1.5) |
Penicillins | 38 | 72 | 0.9 (0.5–1.4) | 1.3 (0.8–2.0) |
Cephalosporin | 21 | 49 | 0.7 (0.4–1.3) | 1.1 (0.7–2.0) |
Macrolides | 7 | 37 | 0.3 (0.1–0.7) | 0.4 (0.2–0.9) |
NSAIDs | 47 | 101 | 0.8 (0.5–1.2) | 0.9 (0.6–1.4) |
Niflumic acid | 12 | 14 | 1.4 (0.6–3.3) | 1.9 (0.6–1.4) |
Ibuprofen | 29 | 61 | 0.8 (0.5–1.3) | 1.1 (0.7–1.7) |
Paracetamol | 62 | 163 | 0.6 (0.4–0.9) | 0.8 (0.6–1.1) |
Corticosteroids | 31 | 104 | 0.5 (0.3–0.8) | 0.8 (0.5–1.3) |
Non users | 113 | 182 |